High Tide stock outlines Canada and Germany growth path

Published on 11/05/2026 at 02:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

High Tide stock is backed by Canadian retail growth and expanding German medical cannabis distribution. Management targets further store and market-share gains.

Growth Across Canada And Germany

Management targets 350 Canadian Canna Cabana stores after reaching 234 locations.
Remexian generated CAD 38 million in quarterly revenue and distributed 10.2 tons of medical cannabis.
U.S. expansion remains dependent on regulatory rescheduling, while the United Kingdom is the next European priority.

HITI, CA42981E4013, Illustration mit AI erstellt.

High Tide outlined a growth plan centered on Canadian cannabis retail and German medical cannabis distribution at the Planet MicroCap Showcase in Toronto on October 28, 2026. Investing.com reported that management sees both businesses as growth engines but remains exposed to regulatory limits and execution risks.

High Tide stock traded at 2.50 euros on Lang & Schwarz at 10:59 p.m. CET on Wednesday, November 4, 2026.

Canada Remains Core Growth Market

Management said Canna Cabana operated 234 stores across five Canadian provinces and is targeting roughly 350 locations over the long term. The company expects most expansion to come organically, with Ontario providing further room under its current store cap.

High Tide said Cabana Club had 2.73 million members, while its paid ELITE tier reached 186,000 members. Management also said more than 45 licensed producers subscribe to the company's data program, which supports product selection and private-label development.

Germany Adds A Second Engine

Remexian Pharma, High Tide's German medical cannabis importer and distributor, generated CAD 38 million in quarterly revenue and handled 10.2 tons of product, according to the company presentation described by Investing.com. Management is targeting a 15 percent market share in Germany over the next two to three years, while acknowledging that import and export permits can make quarterly results uneven.

The United Kingdom is the next priority for European expansion, followed by Poland, France and Spain. Management said a U.S. push would depend on federal rescheduling and broader regulatory clarity rather than forming part of the current operating plan.

Investors can follow the real-time quote of High Tide stock for the latest trading indication.

Retail And Distribution Platform

High Tide describes itself as a retail-focused cannabis company with bricks-and-mortar stores, medical cannabis distribution and international e-commerce assets. Its Canadian Canna Cabana network is complemented by Remexian Pharma in Germany and platforms serving consumption accessories and premium hemp-derived CBD products. The company is headquartered in Calgary, Alberta, and its strategy is built around an integrated cannabis value chain. High Tide competes in a fragmented cannabis market, with its scale concentrated in Canadian retail and its specialization extending into German medical cannabis distribution.